newsfilter
← Latest News
PR Newswire·

Scopus BioPharma Announces Completion of Clinical Lot Manufacture

Scopus BioPharma Inc. (Nasdaq: SCPS) today announced the completion of clinical lot manufacturing fulfilling the requirements for the planned Phase 1 ...